Diabetes drug can improve kidney function: Lancet
A clinical trial of 4,304 participants with CKD revealed that dapagliflozin reduces the rate of kidney function decline in patients with chronic kidney disease (CKD).
Nov 07, 2021, 14:24 PM IST
A clinical trial of 4,304 participants with CKD revealed that dapagliflozin reduces the rate of kidney function decline in patients with chronic kidney disease (CKD).
Nov 07, 2021, 14:24 PM IST